Related Experiment Video
Updated: Jul 5, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Erythema migrans.
Patricia Dandache1, Robert B Nadelman
1Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Erythema migrans (EM) is a key sign of Lyme disease, affecting 90% of cases. Early diagnosis and antibiotic treatment of EM are crucial for excellent outcomes in Borrelia burgdorferi infections.
Area of Science:
- Infectious Diseases
- Dermatology
- Public Health
Background:
- Lyme disease is a tick-borne illness caused by Borrelia burgdorferi.
- Erythema migrans (EM) is the hallmark clinical presentation of early Lyme disease.
- Prompt diagnosis and treatment are essential to prevent disease progression.
Observation:
- EM represents approximately 90% of objective Lyme disease manifestations.
- The characteristic rash is a critical diagnostic indicator.
- Understanding EM epidemiology is vital for public health surveillance.
Findings:
- Early-stage Borrelia burgdorferi infection is effectively treated with oral antibiotics.
- Accurate diagnosis involves clinical evaluation, differential diagnosis, and laboratory testing.
- Timely intervention significantly improves patient outcomes.
Implications:
- Effective management of EM leads to excellent patient outcomes.
- Public health strategies for Lyme disease prevention are informed by EM epidemiology.
- Early antibiotic therapy for EM is a cornerstone of Lyme disease management.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Acute Inflammation II: Cellular Phase
Migration
Rocky Mountain Spotted Fever
Inflammatory Response I: Vascular and Cellular
